Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 2,521 | 2,640 | 3,450 | 3,739 | 2,684 |
| Operating Income | -2,521 | -2,640 | -3,450 | -3,739 | -2,684 |
| Other Income | 0 | -2 | -4 | 0 | -3 |
| Pre-tax Income | -2,521 | -2,642 | -3,454 | -3,739 | -2,687 |
| Net Income Continuous | -2,521 | -2,642 | -3,454 | -3,739 | -2,687 |
| Net Income | $-2,531 | $-2,642 | $-3,451 | $-3,742 | $-2,687 |
| EPS Basic Total Ops | -19.98 | -21.06 | -25.44 | -30.26 | -21.61 |
| EPS Basic Continuous Ops | -19.94 | -21.04 | -26.10 | -29.85 | -21.45 |
| EPS Diluted Total Ops | -19.98 | -21.06 | -25.44 | -30.26 | -21.61 |
| EPS Diluted Continuous Ops | -19.94 | -21.04 | -26.10 | -29.85 | -21.45 |
| EBITDA(a) | $-2,502 | $-2,618 | $-3,430 | $-3,720 | $-2,666 |